These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25602300)

  • 1. Evaluation of age-dependent response to NMDA receptor antagonism in zebrafish.
    Menezes FP; Kist LW; Bogo MR; Bonan CD; Da Silva RS
    Zebrafish; 2015 Apr; 12(2):137-43. PubMed ID: 25602300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient down-regulation of NMDA receptor subunit gene expression in the rat retina following NMDA-induced neurotoxicity is attenuated in the presence of the non-competitive NMDA receptor antagonist MK-801.
    Goebel DJ; Poosch MS
    Exp Eye Res; 2001 May; 72(5):547-58. PubMed ID: 11311046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
    Rujescu D; Bender A; Keck M; Hartmann AM; Ohl F; Raeder H; Giegling I; Genius J; McCarley RW; Möller HJ; Grunze H
    Biol Psychiatry; 2006 Apr; 59(8):721-9. PubMed ID: 16427029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
    Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
    Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist.
    Leung JC; Marphis T; Craver RD; Silverstein DM
    Kidney Int; 2004 Jul; 66(1):167-76. PubMed ID: 15200423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral sensitivity and ethanol potentiation of the N-methyl-D-aspartate receptor antagonist MK-801 in a rat line selected for high ethanol sensitivity.
    Toropainen M; Näkki R; Honkanen A; Rosenberg PH; Laurie DJ; Pelto-Huikko M; Koistinaho J; Eriksson CJ; Korpi ER
    Alcohol Clin Exp Res; 1997 Jun; 21(4):666-71. PubMed ID: 9194922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 prevents the increased NMDA-NR1 and NR2B subunits mRNA expression observed in the hippocampus of rats tolerant to diazepam.
    Almirón RS; Pérez MF; Ramírez OA
    Brain Res; 2004 May; 1008(1):54-60. PubMed ID: 15081382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio).
    Swain HA; Sigstad C; Scalzo FM
    Neurotoxicol Teratol; 2004; 26(6):725-9. PubMed ID: 15451036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats.
    Murray F; Harrison NJ; Grimwood S; Bristow LJ; Hutson PH
    Eur J Pharmacol; 2007 May; 562(3):191-7. PubMed ID: 17321516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
    Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
    Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N-methyl-D-aspartate receptor channels in cultured rat hippocampal neurons.
    Hirai T; Taniura H; Goto Y; Tamaki K; Oikawa H; Kambe Y; Ogura M; Ohno Y; Takarada T; Yoneda Y
    J Neurosci Res; 2005 May; 80(4):491-500. PubMed ID: 15846781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
    J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).
    Seibt KJ; Oliveira Rda L; Zimmermann FF; Capiotti KM; Bogo MR; Ghisleni G; Bonan CD
    Behav Brain Res; 2010 Dec; 214(2):417-22. PubMed ID: 20600350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of very low dose MK-801.
    Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
    Jeziorski M; White FJ; Wolf ME
    Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.